Role of the rs6923761 gene variant in glucagon-like peptide 1 receptor gene on cardiovascular risk factors and weight loss after biliopancreatic diversion surgery

Annals of Nutrition and Metabolism

Volumn 65, Issue 4, 2014, Pages 259-263

  De Luis, Daniel Antonio ^a   Pacheco, David ^a   Aller, Rocío ^a   Izaola, Olatz ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cardiovascular risk factors; Glucagon like peptide 1 receptor; Morbid obesity; Rs6923761

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR;

ADULT; ALLELE; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ANTHROPOMETRY; BLOOD; CARDIOVASCULAR DISEASES; CAUCASIAN; COMPLICATION; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; RISK FACTOR; SPAIN;

NON-A, NON-B HEPATITIS VIRUS;

ANTHROPOMETRY; BILIOPANCREATIC DIVERSION; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, GENETIC; POSTOPERATIVE PERIOD; RECEPTORS, GLUCAGON; RISK FACTORS; SPAIN; WEIGHT LOSS;

EID: 84909957288     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000365975     Document Type: Article

References (20)

1. Jaunoo SS, Southall PJ: Bariatric surgery. Int J Surg 2010; 8: 86-89.
2. Clifton P: Diabetes: Treatment of type 2 diabetes mellitus with bariatric surgery. Nat Rev Endocrinol 2010; 6: 191-193.
3. Kashyap SR, Gatmaitan P, Brethauer S, et al: Bariatric surgery for type 2 diabetes: Weighing the impact for obese patients. Cleve Clin J Med 2010; 77: 468-476.
4. Lee WJ, Ser KH, Chong K, et al: Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: Efficacy and change of insulin secretion. Surgery 2010; 147: 664-669.
5. Chen HH, Lee WJ, Wang W, et al: Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding. Obes Surg 2007; 17: 926-933.
6. Clifton P: Diabetes: Treatment of type 2 diabetes mellitus with bariatric surgery. Nat Rev Endocrinol 2010; 6: 191-193.
7. Kieffer TJ, Habener JF: The glucagon-like peptides. Endocr Rev 1999; 20: 876-913.
8. Bullock BP, Heller RS, Habener JF: Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 1996; 137: 2968-2978.
9. Thorens B: Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon peptide-1. Proc Natl Acad Sci USA 1992; 89: 8641-8645.
10. Tokuyama Y, Matsui K, Egashira T, Nozaki O, Ishizuka T, Kanatsuka A: Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population. Diabetes Res Clin Pract 2004; 66: 63-69.
11. Beinborn M, Worrall CI, McBride MW, Kopin AS: A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 2005; 130: 1-6.
12. Sathananthan A, Dalla C, Micheletto F, ZInsmeister A, Camilleri M, Giesler P: Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects. Diabetes Care 2010; 33: 2074-2076.
13. De Luis DA, Aller R, Izaola O, Pacheco D: Early clinical and surgical results of biliopancreatic diversion. Obes Surg 2005; 15: 799-802.
14. American Diabetes Association: Standards of diabetes mellitus. Diabetes Care 2007; 30: S4-S41.
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2487.
16. Fortin JP, Schroeder J, Zhu Y, Beinborn M, Kopin A: Pharmacological characterization of human incretin receptor missense. J Pharmacol Exp Ther 2010; 332: 274-280.
17. Scrocchi LA, Marshall BA, Cook SM, Brubaker DJ: Identification of GLP-1 actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 1998; 47: 632-639.
18. Barash A, de Grado T, Cano O, Bordiu E: Effect of GLP-1 receptor variants on weight loss and comorbidities in obese patients under bariatric surgery (abstract). 54th Congr Endocrinol Soc, Madrid, 2012.
19. De Luis DA, Aller R, Izaola O, Bachiller R, Pacheco D: Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor. J Endocrinol Invest 2014, Epub ahead of print.
20. De Luis DA, Aller R, Izaola O, Lopez JJ, Gomez E, Torres B, Soto GD: Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet. J Endocrinol Invest 2014, Epub ahead of print.